Drug Information

Drug General Information
Drug ID
D0M2EN
Former ID
DNC013716
Drug Name
N-butylresorcinol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529942]
Formula
C10H14O2
Canonical SMILES
CCCCC1=C(C=C(C=C1)O)O
InChI
1S/C10H14O2/c1-2-3-4-8-5-6-9(11)7-10(8)12/h5-7,11-12H,2-4H2,1H3
InChIKey
CSHZYWUPJWVTMQ-UHFFFAOYSA-N
PubChem Compound ID
205912
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [529942]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 529942Bioorg Med Chem Lett. 2009 Mar 1;19(5):1532-3. Epub 2009 Jan 1.Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.
Ref 529942Bioorg Med Chem Lett. 2009 Mar 1;19(5):1532-3. Epub 2009 Jan 1.Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.